American Century Companies’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-93,736
Closed -$241K 2976
2024
Q1
$241K Buy
+93,736
New +$229K ﹤0.01% 2719
2023
Q3
Sell
-38,045
Closed -$74.2K 2900
2023
Q2
$74.2K Buy
38,045
+18,766
+97% +$43.9K ﹤0.01% 2721
2023
Q1
$49.9K Buy
19,279
+8,859
+85% +$25.3K ﹤0.01% 2625
2022
Q4
$35.9K Buy
+10,420
New +$29.7K ﹤0.01% 2555

Other funds holding GRTS

American Century Companies's GRTS Position: Q2 2024 in Review

American Century Companies sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2024, closing a stake of 93,736 shares — an estimated $241K sold.

American Century Companies first reported a position in GRTS in Q4 2022 and held it in 4 quarters. The position peaked at $241K in Q1 2024. 79 funds tracked by Wall St. Rank hold GRTS as of Q2 2024.

  • American Century Companies reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • American Century Companies sold 93,736 Gritstone bio, Inc. Common Stock shares in Q2 2024, an estimated $241K.
  • American Century Companies first reported a position in Gritstone bio, Inc. Common Stock in Q4 2022 and held it in 4 quarters.
  • American Century Companies's Gritstone bio, Inc. Common Stock position peaked at $241K in Q1 2024.
  • 79 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2024.

Based on American Century Companies's 13F filing for Q2 2024, filed 7 Aug 2024.